Degussa AG is the world's third largest producer of precious metals. The company operates three divisions; precious metals and banking, which is involved in precious metals trading, production of precious metals and the manufacture of precious metal compounds and products in addition to operating its own bank, 'Degussa Bank', which is a universal bank providing traditional banking services. Chemical products is the second division and is involved in manufacturing fine and special chemicals, rubbers, pigments and chemical catalysts. The third and final division, health and nutrition is involved in manufacturing pharmaceuticals, dental chemicals and fodder additives. The company has subsidiaries in Germany, other European countries, USA, Brazil, Singapore, Japan and South Korea.

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in over 200 countries and territories throughout the world. It operates in two segments: Oral, Personal and Home Care and Pet Nutrition. Oral Care business products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh, Colgate Optic White, and Colgate Luminous White toothpastes, Colgate 360° manual toothbrushes and Colgate and Colgate Plax mouth rinses. Colgate's Oral Care business also includes dental floss and pharmaceutical products for dentists and oral health professionals. Its Personal Care products also include Palmolive, Softsoap and Sanex brand shower gels, Palmolive, Irish Spring, and Protex bar soaps and Speed Stick, Lady Speed Stick and Sanex deodorants and antiperspirants. It sells liquid hand soap under the Palmolive, Protex and Softsoap brands. Colgate, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

Efamol Ltd., a subsidiary of Infinitus Holdings (Pty) Ltd., is a company headquartered in Hessle, UK, that produces and sells food supplements through online. It was founded in 1977 by David Horrobin. On November 01, 1998 Nutricia Holdings Plc acquired Efamol Ltd. from Scotia Holdings Plc for $27.12 million.\nThe company says this about itself: Efamol specialises in essential fatty acid (EFAs) based products, the so called \"good fats\" that are essential for the healthy functioning of every cell in the human body. These \"good fats\" are from the Omega-3 and Omega-6 families of nutrients and are sourced from high quality fish oils and evening primrose oil.

Nanjing Xingfuxing Pharmaceutical Technology Co., Ltd., established on 2016-01-26, Business scope includes medical technology research and development,technology transfer;Pharmaceutical investment information consultation;Chemical Products(Does not contain dangerous goods)Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Laboratoires Expanscience SA manufactures and commercializes cosmetics and pharmaceutical products. It encompasses the fields of derma-cosmetics, rheumatology, dental care, dermatology, and active cosmetic ingredients. The company was founded by Jean-Paul Louis Berthomé in 1950 and is headquartered in Paris, France.

Hanmi Science Co., Ltd. engages in the management of its subsidiaries. It is mainly engaged in the manufacturing and selling of pharmaceutical ingredients and intermediates. The company was founded on June 15,1973 and is headquartered in Hwaseong-si, South Korea.

Nichi-Iko Pharmaceutical Co., Ltd. is the largest generic drug manufacturer in Japan by sales. In FY2014, it became the first Japanese generic medicine manufacturer to reach JPY100 billion in annual sales, and consolidated net sales in the fiscal year ended March 31, 2016 reached JPY143.5 billion. Since its establishment in 1965, Nichi-Iko has earned a reputation for operating at the forefront of quality assurance with premium quality generic pharmaceuticals. It has grown market share with an extensive lineup of more than 1,000 commercialized products — the largest number among domestic pharmaceutical manufacturers — as well as strong relationships with wholesalers. Nichi-Iko’s development has been enhanced by six acquisitions and nine business alliances since the appointment of current President & CEO Yuichi Tamura in 2000. Nichi-Iko employs 1,142 people and operates seven production sites, one R&D facility, and four distribution centers throughout Japan. In Obelisk, its seventh Medium-term Business Plan for the three fiscal years from April 2016 through March 2019, Nichi-Iko aims to become a global Top 10 generics company, underpinned by three core strategies: Power of Expansion, Power of Production, and Power of Development.

Shandong Xinke Marine Biotechnology Co., Ltd., established on 2013-02-07, Business scope includes biomedicine,Technology development in the field of medical technology expertise,technology transfer,technical consulting;one,two,Research and development of three types of medical devices,Production,Sales;Facial mask,eye mask,Hand and foot mask beauty care products,Cleaning fabrics and their products,Home Textiles,clothing,Labor protection products,disinfection products(Free of Hazardous Chemicals,Precursor chemicals and flammable and explosive substances),Production of personal hygiene care products,Sales;food,daily necessities,Health Supplies,cosmetic,electronic product,Agricultural and sideline products,Chemical Products(Free of Hazardous Chemicals,Precursor chemicals and flammable and explosive substances)promotion of;Import and export business of agent or self-operated and network sales of various commodities or technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bioscience International is an environmental sampling product seller and manufacturer. They market items like the SAS 100 and SAS 180 high-volume microbial air samplers and associated air monitoring gear, which are used by hospitals and pharmaceutical companies all over the world for air quality testing and microbial contamination detection, as well as by substantial governmental organizations like NASA and NIH.

Aventis Animal Nutrition SA manufactures nutritional feed additives for animal feed. The company is headquartered in Paris, France.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Beijing Xintianyu Technology Development Co., Ltd., established on 2011-10-21, Business scope includes(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Leiras Oy, part of Bayer AG, is a company headquartered in Turku, Finland. The firm develops pharmaceutical solutions. It was acquired by Nycomed Pharma Holding An on May 31, 2003 for $49.44 million.

Shandong Zhuolai Biotechnology Co., Ltd., established on 2015-01-05, Business scope includes biotechnology,veterinary medicine,medicine,cosmetic,Health products,Disinfectant,daily necessities,Technology research and development of health food,to promote(Does not include production);General cargo import and export(Items subject to approval by law,Business activities can only be carried out with the approval of relevant departments).

Evonik Operations GmbH manufactures specialty chemicals. The company was founded on August 23, 2000 and is headquartered in Weatherford, TX.